Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in BMJ Retrieve available abstracts of 34 articles: HTML format

Single Articles

April 2025
1. JIANG H
   No-touch vein harvesting in coronary artery bypass surgery.
   BMJ. 2025;389:r728.
   PubMed    
   
   
   
2. TIAN M, Wang X, Feng W, Wang H, et al
   No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
   BMJ. 2025;389:e082883.
   PubMed     Abstract available
   
   
   March 2025
3. GAO C, Zhu B, Ouyang F, Wen S, et al
   Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial.
   BMJ. 2025;388:e082945.
   PubMed     Abstract available
   
   
   
4. BELLOLIO F, Gottlieb M, Body R, Than MP, et al
   Evaluating patients with chest pain in the emergency department.
   BMJ. 2025;388:r136.
   PubMed     Abstract available
   
   
   
5. HAN J, Zhai W, Wu Z, Zhang Z, et al
   Care guided by tissue oxygenation and haemodynamic monitoring in off-pump coronary artery bypass grafting (Bottomline-CS): assessor blind, single centre, randomised controlled trial.
   BMJ. 2025;388:e082104.
   PubMed     Abstract available
   
   
   February 2025
6. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
   Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
   BMJ. 2025;388:e082801.
   PubMed     Abstract available
   
   
   
7. WISE J
   Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports.
   BMJ. 2025;388:r287.
   PubMed    
   
   
   January 2025
8. HU W, Tao C, Wang L, Chen Z, et al
   Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial.
   BMJ. 2025;388:e080489.
   PubMed     Abstract available
   
   
   November 2024
9. JOHANSSON T, Karlsson T, Bliuc D, Schmitz D, et al
   Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial.
   BMJ. 2024;387:e078784.
   PubMed     Abstract available
   
   
   
10. MAHASE E
    Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds.
    BMJ. 2024;387:q2518.
    PubMed    
    
    
    October 2024
11. 
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;387:q2381.
    PubMed    
    
    
    
12. LU J, Xu Y, Bi Y, Wang T, et al
    Reducing inequity through tackling social determinants of cardiovascular diseases in China.
    BMJ. 2024;387:e079197.
    PubMed    
    
    
    September 2024
13. INOUE K, Athey S, Baicker K, Tsugawa Y, et al
    Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2024;386:e079377.
    PubMed     Abstract available
    
    
    
14. YANG C, Tebbutt SJ
    Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2024;386:q1807.
    PubMed     Abstract available
    
    
    August 2024
15. MENG R, Wang W, Huang T, Zhan S, et al
    Tackling social and behavioural risk factors for cardiovascular diseases in Chinese women.
    BMJ. 2024;386:e078638.
    PubMed    
    
    
    
16. MAHASE E
    Incidence of cardiovascular events was lower after covid-19 vaccination, study finds.
    BMJ. 2024;386:q1732.
    PubMed    
    
    
    July 2024
17. IACOBUCCI G
    Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
    BMJ. 2024;386:q1660.
    PubMed    
    
    
    June 2024
18. 
    Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
    BMJ. 2024;385:q1450.
    PubMed    
    
    
    
19. CONRAD N, Molenberghs G, Verbeke G, Zaccardi F, et al
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;385:e078523.
    PubMed     Abstract available
    
    
    
20. ZHU Y, Zhang W, Dimagli A, Han L, et al
    Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    BMJ. 2024;385:e075707.
    PubMed     Abstract available
    
    
    
21. SANDNER S
    Dual antiplatelet therapy after coronary artery bypass surgery.
    BMJ. 2024;385:q1083.
    PubMed    
    
    
    
22. 
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1237.
    PubMed    
    
    
    May 2024
23. DYER C
    Former cardiovascular surgery lead is charged with 14 counts of sexual assault.
    BMJ. 2024;385:q1188.
    PubMed    
    
    
    
24. 
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:q1197.
    PubMed    
    
    
    
25. 
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1094.
    PubMed    
    
    
    
26. PALASKAS NL, Ali HJ, Koutroumpakis E, Ganatra S, et al
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:e075859.
    PubMed     Abstract available
    
    
    
27. LI Z, Min XW, He PG, Zhang CH, et al
    Chest pain with diffuse ST segment elevation.
    BMJ. 2024;385:e078403.
    PubMed    
    
    
    April 2024
28. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    PubMed     Abstract available
    
    
    
29. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
    Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
    BMJ. 2024;385:e076268.
    PubMed     Abstract available
    
    
    
30. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
    Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
    BMJ. 2024;385:e077209.
    PubMed     Abstract available
    
    
    March 2024
31. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
    Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
    BMJ. 2024;384:q637.
    PubMed    
    
    
    
32. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    PubMed     Abstract available
    
    
    
33. TANNE JH
    Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
    BMJ. 2024;384:q642.
    PubMed    
    
    
    February 2024
34. 
    Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:q517.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.